16 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AMUKIN D

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

Tubifast®

FDA UDI
Mölnlycke Health Care AB·05055158000742·Tubifast Leggings 11 - 14 yrs x 6

Inrad

FDA UDI
Inrad·00817295020695·SelectCore Variable Throw Biopsy Device 16 ga x...

SCOTT'S SELECT MICROHYBRID SYRINGE 4.5 Gm (D3)

FDA UDI
SCOTT'S DENTAL SUPPLY L.L.C.·D77819920160·Scott’s Select Microhybrid Composite is indicat...

SUPER-FINE PEN NEEDLE

FDA 510(k)
FDA Class 2 ·General Hospital

SMOOV O10

FDA 510(k)
FDA Class 2 ·Physical Medicine

NexGen® Legacy®

FDA UDI
Zimmer, Inc.·00889024224629·

NexGen® Legacy®

FDA UDI
Zimmer, Inc.·00889024224636·

PLUM A+ TRIPLE NEW 8

FDA Adverse Event
Malfunction ·HOSPIRA COSTA RICA LTD.·Product code FRN·January 28, 2016

ACCU-CHEK ® SPIRIT COMBO

FDA Adverse Event
Malfunction ·ROCHE DIABETES CARE AG·Product code LZG·March 7, 2013

CONCERTO CRT-D DR

FDA Adverse Event
Injury ·MEDTRONIC MED REL, INC.·Product code NIK·February 15, 2011

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·August 8, 2014

13X75 MM 4.0 ML BD VACUTAINER® PLUS PLASTIC WHOLE BLOOD TUBE

FDA Adverse Event
Injury ·BECTON, DICKINSON & CO.·Product code JKA·July 25, 2017

13X75 MM 4.0 ML BD VACUTAINER® PLUS PLASTIC WHOLE BLOOD TUBE

FDA Adverse Event
Injury ·BECTON, DICKINSON & CO.·Product code JKA·July 25, 2017

LPS PRECOAT FEM SIZE D-RT LPS PRECOAT FEM SIZE E-RT LPS POROUS FEM SIZE F-RT This device is indicated for patients with severe knee pain and disability

FDA Enforcement
Class II ·Terminated·Zimmer Biomet, Inc.·March 21, 2018

NexGen Knee CR Option Fem NexGen Knee CR Porous Fem NexGen Knee CR Precoat Fem NexGen Knee LPS Porous Fem NexGen Knee LPS Precoat Fem prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer/metal/polymer various sizes This device is indicated for patients with severe knee pain and disability due to: Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis. Collagen disorders, and/or avascular necrosis of the femoral condyle. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy. Moderate valgus, varus, or flexion deformities. The salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery. " CR and LPS porous coated femoral and tibial baseplate components may be used cemented or uncemented (biological fixation). The CR Hydroxyapatite/tricalcium phosphate [HA/TCP] coated femoral or tibial baseplate components may only be used uncemented. All other femoral, tibial baseplate and all-polyethylene patella components are indicated for cemented use only."

FDA Enforcement
Class II ·Terminated·Zimmer Biomet, Inc.·March 2, 2016